Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance.

Abstract:

:E-proteins are widely expressed basic helix-loop-helix (HLH) transcription factors that regulate differentiation in many cell lineages, including lymphoid, muscle, and neuronal cells. E-protein function is controlled by HLH inhibitors such as Id and SCL/TAL1 proteins, which recently have been suggested to play a role in hematopoietic stem cell (HSC) differentiation. However, the precise stages when these proteins are expressed and their specific functions are not entirely clear. Using a knock-in mouse model where the sequence for the enhanced green fluorescent protein (GFP) was inserted downstream of the Id1 promoter, we were able to track Id1 expression on an individual cell basis and detected Id1 expression in long-term repopulating HSCs (LT-HSCs). Functional assays showed that the Id1/GFP(+)Lin(-)Sca1(+)c-kit(Hi) population was highly enriched for LT-HSCs. Consistent with this expression pattern, Id1 deficiency led to a 2-fold reduction in the number of LT-HSCs defined as Lin(-)Sca1(+)c-kit(Hi)CD48(-)CD150(+). Primary bone marrow transplantation studies revealed that Id1 is dispensable for short-term engraftment. In contrast, both Id1(-/-) whole bone marrow and Lin(-)Sca1(+)c-kit(Hi)Thy1.1(Lo)-enriched HSCs, but not Id3(-/-) marrow, displayed impaired engraftment relative to wild-type controls in secondary transplantation assays. These findings suggest a unique role for Id1 in LT-HSC maintenance and hematopoietic development.

journal_name

Blood

journal_title

Blood

authors

Perry SS,Zhao Y,Nie L,Cochrane SW,Huang Z,Sun XH

doi

10.1182/blood-2007-01-069914

subject

Has Abstract

pub_date

2007-10-01 00:00:00

pages

2351-60

issue

7

eissn

0006-4971

issn

1528-0020

pii

blood-2007-01-069914

journal_volume

110

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.

    abstract::Cumulative evidence indicates that MYC, one of the major downstream effectors of NOTCH1, is a critical component of T-cell acute lymphoblastic leukemia (T-ALL) oncogenesis and a potential candidate for targeted therapy. However, MYC is a complex oncogene, involving both fine protein dosage and cell-context dependency,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336842

    authors: Bonnet M,Loosveld M,Montpellier B,Navarro JM,Quilichini B,Picard C,Di Cristofaro J,Bagnis C,Fossat C,Hernandez L,Mamessier E,Roulland S,Morgado E,Formisano-Tréziny C,Dik WA,Langerak AW,Prebet T,Vey N,Michel G,Gabert

    更新日期:2011-06-16 00:00:00

  • A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.

    abstract::An unmet need in cell engineering is the availability of a single transgene encoded, functionally inert, human polypeptide that can serve multiple purposes, including ex vivo cell selection, in vivo cell tracking, and as a target for in vivo cell ablation. Here we describe a truncated human EGFR polypeptide (huEGFRt) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-337360

    authors: Wang X,Chang WC,Wong CW,Colcher D,Sherman M,Ostberg JR,Forman SJ,Riddell SR,Jensen MC

    更新日期:2011-08-04 00:00:00

  • How we manage autologous stem cell transplantation for patients with multiple myeloma.

    abstract::An estimated 22 350 patients had multiple myeloma diagnosed in 2013, representing 1.3% of all new cancers; 10 710 deaths are projected, representing 1.8% of cancer deaths. Approximately 0.7% of US men and women will have a myeloma diagnosis in their lifetime, and with advances in therapy, 77 600 US patients are living...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-03-544759

    authors: Gertz MA,Dingli D

    更新日期:2014-08-07 00:00:00

  • FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.

    abstract::FTY720 is an immunosuppressant developed to prevent organ transplant rejection. Recent studies indicate an additional role for FTY720 in inducing cell apoptosis. We demonstrate here that FTY720 mediates toxic effects in cell lines representing different B-cell malignancies and primary B cells from patients with chroni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-053884

    authors: Liu Q,Zhao X,Frissora F,Ma Y,Santhanam R,Jarjoura D,Lehman A,Perrotti D,Chen CS,Dalton JT,Muthusamy N,Byrd JC

    更新日期:2008-01-01 00:00:00

  • Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

    abstract::Treatment outcome of acute myeloid leukemia (AML) in elderly patients remains unsatisfactory. It has been shown that the infusion of granulocyte colony-stimulating factor-mobilized donor peripheral blood stem cells (G-PBSCs) can enhance graft-versus-leukemia effects and speed hematopoietic recovery. Fifty-eight AML pa...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-06-288506

    authors: Guo M,Hu KX,Yu CL,Sun QY,Qiao JH,Wang DH,Liu GX,Sun WJ,Wei L,Sun XD,Huang YJ,Qiao JX,Dong Z,Ai HS

    更新日期:2011-01-20 00:00:00

  • Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.

    abstract::The purpose of this report was to evaluate scintigraphy analysis of Southern blot hybridization as a method to quantify the breakpoint cluster region (BCR) rearrangement of Philadelphia chromosome (Ph)+ chronic myelogenous leukemia (CML). Cytogenetic and molecular studies performed simultaneously on 474 bone marrow an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Verschraegen CF,Talpaz M,Hirsch-Ginsberg CF,Pherwani R,Rios MB,Stass SA,Kantarjian HM

    更新日期:1995-05-15 00:00:00

  • HLA associations with leukemia.

    abstract::Frequencies of 35 HLA A, B, C, and DR antigens were determined in 1,834 leukemic Caucasoids to evaluate possible associations between HLA and leukemia. In comparison with the frequencies of HLA antigens in published controls, the frequency of Cw3 was significantly higher in patients with acute lymphoblastic leukemia (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bortin MM,D'Amaro J,Bach FH,Rimm AA,van Rood JJ

    更新日期:1987-07-01 00:00:00

  • IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo.

    abstract::Interleukin 21 (IL-21) is a member of the common gamma-chain family of cytokines, which influence a broad spectrum of immunologic responses. A number of studies have examined the function of IL-21, but its specific role in Th1/Th2-cell differentiation and related effector responses remains to be clarified. Thus, we ge...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021600

    authors: Fröhlich A,Marsland BJ,Sonderegger I,Kurrer M,Hodge MR,Harris NL,Kopf M

    更新日期:2007-03-01 00:00:00

  • Deficient MHC class I cross-presentation of soluble antigen by murine neonatal dendritic cells.

    abstract::Neonates respond suboptimally to many vaccines. The reasons for this defect are unclear, but suboptimal antigen presentation by dendritic cells has been suggested as one possibility. In this report we describe an in vitro system that allows the generation of large numbers of resting murine neonatal dendritic cells fac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3805

    authors: Kollmann TR,Way SS,Harowicz HL,Hajjar AM,Wilson CB

    更新日期:2004-06-01 00:00:00

  • Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production.

    abstract::We have identified and cloned a novel human cytokine with homology to cytokines of the interleukin-17 (IL-17) family, which we have termed human IL-17E (hIL-17E). With the identification of several IL-17 family members, it is critical to understand the in vivo function of these molecules. We have generated transgenic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0012

    authors: Kim MR,Manoukian R,Yeh R,Silbiger SM,Danilenko DM,Scully S,Sun J,DeRose ML,Stolina M,Chang D,Van GY,Clarkin K,Nguyen HQ,Yu YB,Jing S,Senaldi G,Elliott G,Medlock ES

    更新日期:2002-10-01 00:00:00

  • Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

    abstract::Liver injury is a frequent, serious complication of allogeneic hematopoietic cell transplantation (HCT) following myeloablative preparative regimens. We sought to determine the frequency and severity of hepatic injury after nonmyeloablative conditioning and its relationship to outcomes. One hundred ninety-three consec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1311

    authors: Hogan WJ,Maris M,Storer B,Sandmaier BM,Maloney DG,Schoch HG,Woolfrey AE,Shulman HM,Storb R,McDonald GB

    更新日期:2004-01-01 00:00:00

  • Acute hyperviscosity: syndromes and management.

    abstract::Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients w...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-06-846816

    authors: Gertz MA

    更新日期:2018-09-27 00:00:00

  • Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.

    abstract::The transcription factor signal transducer and activator of transcription 5 (STAT5) fulfills essential roles in self-renewal in mouse and human hematopoietic stem cells (HSCs), and its persistent activation contributes to leukemic transformation, although little molecular insight into the underlying mechanisms has bee...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-303669

    authors: Fatrai S,Wierenga AT,Daenen SM,Vellenga E,Schuringa JJ

    更新日期:2011-03-24 00:00:00

  • CD30: seeing is not always believing.

    abstract::Although most investigators are well aware of the incredible success of brentuximab vedotin in the treatment of patients with Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL), the study by Jacobsen and colleagues in this issue of Blood demonstrates surprising activity of this agent in patients with B-ce...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-01-622480

    authors: Blum KA

    更新日期:2015-02-26 00:00:00

  • Can Treg elimination enhance NK cell therapy for AML?

    abstract::In this issue of Blood, Bachanova et al describe how modulation of the inhibitory tumor environment may enhance natural killer (NK) cell clinical activity and produce encouraging results in the treatment of refractory acute myeloid leukemia (AML). NK cells are highly proliferative, early responders of the innate immun...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-05-570291

    authors: Rooney CM

    更新日期:2014-06-19 00:00:00

  • Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.

    abstract::Outcome in multiple myeloma is highly variable and a better understanding of the factors that influence disease biology is essential to understand and predict behavior in individual patients. In the present study, we analyzed combined genomewide DNA methylation and gene expression data of patients treated in the Medic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-03-487884

    authors: Kaiser MF,Johnson DC,Wu P,Walker BA,Brioli A,Mirabella F,Wardell CP,Melchor L,Davies FE,Morgan GJ

    更新日期:2013-07-11 00:00:00

  • Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression.

    abstract::We have used a combination of hematopoietic growth factors to induce in vitro granulocytic maturation. A fraction of marrow cells enriched for hematopoietic progenitor cells (CD34+, HLA-DR+) was isolated from normal human bone marrow by monoclonal antibody staining and fluorescence-activated cell sorting. Cells were c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Berliner N,Hsing A,Graubert T,Sigurdsson F,Zain M,Bruno E,Hoffman R

    更新日期:1995-02-01 00:00:00

  • Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.

    abstract::The present study sought to determine the impact of the route of administration of an adeno-associated virus (AAV) vector encoding human factor IX (hFIX) on the induction of an immune response against the vector and its xenogenic transgene product, hFIX. Increasing doses of AAV-hFIX were administered by different rout...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.12.3733

    authors: Ge Y,Powell S,Van Roey M,McArthur JG

    更新日期:2001-06-15 00:00:00

  • Why "R" HIT patients predisposed to thrombosis?

    abstract::In this issue of Blood, Rollin et al demonstrate that heparin-induced thrombocytopenia and thrombosis (HIT) patients homozygous for arginine (R) at position 131 in the immunoglobulin (Ig)G receptor FcγRIIA have a significantly higher incidence of thrombosis, and show that plasma IgG may play a key role in modulating t...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-02-629782

    authors: Padmanabhan A

    更新日期:2015-04-09 00:00:00

  • Pattern of pyruvate kinase isozymes in erythroleukemia cell lines and in normal human erythroblasts.

    abstract::To further investigate the erythroid nature of the two human erythroleukemia cell lines, K562 and HEL-60, and to define the ontogeny of pyruvate kinase (PK) isozymes (R, M2) in developing human erythroid cells, we have studied the isozymic alterations, if any, during differentiation of these cell lines in vitro and no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Max-Audit I,Testa U,Kechemir D,Titeux M,Vainchenker W,Rosa R

    更新日期:1984-10-01 00:00:00

  • N(o)-cadherin role for HSCs.

    abstract::In this issue of Blood, Bromberg et al and Greenbaum et al delete the gene encoding the cell adhesion molecule N-cadherin in osteoblastic cells forming the hematopoietic stem cell (HSC) niche to demonstrate that N-cadherin has no role in regulating hematopoiesis. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-05-431148

    authors: Levesque JP

    更新日期:2012-07-12 00:00:00

  • SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.

    abstract::The Sox4 transcription factor mediates early B-cell differentiation. Compared with normal pre-B cells, SOX4 promoter regions in Ph(+) ALL cells are significantly hypomethylated. Loss and gain-of-function experiments identified Sox4 as a critical activator of PI3K/AKT and MAPK signaling in ALL cells. ChIP experiments c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-428938

    authors: Ramezani-Rad P,Geng H,Hurtz C,Chan LN,Chen Z,Jumaa H,Melnick A,Paietta E,Carroll WL,Willman CL,Lefebvre V,Müschen M

    更新日期:2013-01-03 00:00:00

  • Cyclophosphamide metabolism is affected by azole antifungals.

    abstract::We performed a randomized trial to compare the safety and efficacy of itraconazole with fluconazole in preventing fungal infections in patients undergoing allogeneic stem cell transplantation (SCT). Itraconazole (intravenous 200 mg daily, or oral solution 2.5 mg/kg 3 times daily) and fluconazole (intravenous or oral, ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2003-07-2512

    authors: Marr KA,Leisenring W,Crippa F,Slattery JT,Corey L,Boeckh M,McDonald GB

    更新日期:2004-02-15 00:00:00

  • Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.

    abstract::Mutations in CCAAT/enhancer binding protein alpha (CEBPA) are seen in 5% to 14% of acute myeloid leukemia (AML) and have been associated with a favorable clinical outcome. Most AMLs with CEBPA mutations simultaneously carry 2 mutations (CEBPA(double-mut)), usually biallelic, whereas single heterozygous mutations (CEBP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-179895

    authors: Wouters BJ,Löwenberg B,Erpelinck-Verschueren CA,van Putten WL,Valk PJ,Delwel R

    更新日期:2009-03-26 00:00:00

  • Isolation and characterization of an age-related antigen present on senescent human red blood cells.

    abstract::Autologous membrane-bound IgG was isolated from a subpopulation of human red blood cells (RBC) with specific density greater than 1.110, by affinity chromatography of purified RBC membrane glycoprotein preparations using immobilized wheat germ agglutinin and immobilized anti-human immunoglobulin (Ig) as immunoabsorben...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alderman EM,Fudenberg HH,Lovins RE

    更新日期:1981-08-01 00:00:00

  • Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines.

    abstract::Induced pluripotent stem cells (iPSCs) hold great promise for modeling human hematopoietic diseases. However, intrinsic variability in the capacities of different iPSC lines for hematopoietic development complicates comparative studies and is currently unexplained. We created and analyzed 3 separate iPSC clones from f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-02-484444

    authors: Mills JA,Wang K,Paluru P,Ying L,Lu L,Galvão AM,Xu D,Yao Y,Sullivan SK,Sullivan LM,Mac H,Omari A,Jean JC,Shen S,Gower A,Spira A,Mostoslavsky G,Kotton DN,French DL,Weiss MJ,Gadue P

    更新日期:2013-09-19 00:00:00

  • Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3.

    abstract::Follicular lymphoma (FL) grades 1 and 2 are regarded as a distinct disease entity, whereas data suggest that FL grade 3 might be an inhomogeneous tumor category. To define the biologic spectrum of FL, 89 follicular lymphomas were studied for their cytologic composition, antigen expression, mitotic and proliferation in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3806

    authors: Ott G,Katzenberger T,Lohr A,Kindelberger S,Rüdiger T,Wilhelm M,Kalla J,Rosenwald A,Müller JG,Ott MM,Müller-Hermelink HK

    更新日期:2002-05-15 00:00:00

  • Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells.

    abstract::Natural killer (NK) cells contribute to host immunity, including tumor surveillance, through the production of interferon gamma (IFN-gamma). Although there is some knowledge about molecular mechanisms that induce IFN-gamma in NK cells, considerably less is known about the mechanisms that reduce its expression. Here, w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-050096

    authors: Becknell B,Hughes TL,Freud AG,Blaser BW,Yu J,Trotta R,Mao HC,Caligiuri de Jesús ML,Alghothani M,Benson DM Jr,Lehman A,Jarjoura D,Perrotti D,Bates MD,Caligiuri MA

    更新日期:2007-03-15 00:00:00

  • High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.

    abstract::Seventy-five patients with resistant acute leukemia or lymphoma received high-dose cyclophosphamide and etoposide to explore the activity of this combination in resistant hematologic malignancies, and to determine the maximum doses of these drugs that can be combined without bone marrow transplantation. Etoposide was ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brown RA,Herzig RH,Wolff SN,Frei-Lahr D,Pineiro L,Bolwell BJ,Lowder JN,Harden EA,Hande KR,Herzig GP

    更新日期:1990-08-01 00:00:00

  • Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations.

    abstract::Venomous snakes produce an array of toxic compounds, including procoagulants to defend themselves and incapacitate prey. The Australian snake Pseudonaja textilis has a venom-derived prothrombin activator homologous to coagulation factors V (FV) and Xa (FXa). Here we show that the FV component (pt-FV) has unique biolog...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-202663

    authors: Bos MH,Boltz M,St Pierre L,Masci PP,de Jersey J,Lavin MF,Camire RM

    更新日期:2009-07-16 00:00:00